Skip to main content
. 2020 Feb 10;20:32. doi: 10.1186/s12876-020-1178-7

Table 3.

Incidence rates and hazard ratios of non-alcoholic fatty liver disease according to sleep disorder status

Comparison Cohort Sleep Disorder Cohort Compared to the Comparison Cohort
Hazard Ratio (95% Confidence Interval)
Characteristics Event Person-year IR Event Person-year IR Crude p-value Adjusteda p-value
Sex
 Women 65 142,160 4.6 260 195,118 13.3 2.92 (2.22–3.83) < 0.001 1.82 (1.35–2.46) < 0.001
 Men 141 190,961 7.4 181 119,509 15.2 2.04 (1.64–2.54) < 0.001 1.79 (1.38–2.32) < 0.001
Age (year)
 20–39 88 183,841 4.8 78 76,805 10.2 2.11 (1.55–2.86) < 0.001 1.71 (1.18–2.48) 0.004
 40–59 89 111,058 8.0 248 134,146 18.5 2.31 (1.81–2.94) < 0.001 1.89 (1.44–2.47) < 0.001
  ≥ 60 29 38,222 7.6 115 103,676 11.1 1.46 (0.97–2.20) 0.07 1.23 (0.79–1.91) 0.35
Comorbidities
 Diabetes
  No 186 320,194 5.8 370 272,633 13.6 2.34 (1.96–2.79) < 0.001 1.84 (1.50–2.26) < 0.001
  Yes 20 12,927 15.5 71 41,995 16.9 1.11 (0.68–1.82) 0.68 1.17 (0.68–1.99) 0.57
 Dyslipidemia
  No 153 309,909 4.9 258 234,156 11.0 2.24 (1.83–2.73) < 0.001 2.10 (1.67–2.65) < 0.001
  Yes 53 23,212 22.8 183 80,471 22.7 0.99 (0.74–1.36) 0.99 1.03 (0.74–1.44) 0.85
 Hypertension
  No 157 295,681 5.3 250 183,442 13.6 2.56 (2.10–3.13) < 0.001 2.03 (1.61–2.57) < 0.001
  Yes 49 37,440 13.1 191 131,186 14.6 1.12 (0.82–1.53) 0.49 1.09 (0.78–1.52) 0.61
 Ischemic heart disease
  No 190 319,112 6.0 339 241,780 14.0 2.35 (1.97–2.81) < 0.001 1.88 (1.53–2.31) < 0.001
  Yes 16 14,009 11.4 102 72,847 14.0 1.23 (0.73–2.09) 0.44 1.04 (0.60–1.82) 0.88
 Depression
  No 203 331,189 6.1 371 275,610. 13.5 2.19 (1.85–2.60) < 0.001 1.81 (1.48–2.20) < 0.001
  Yes 3 1932 15.5 70 39,017 17.9 1.16 (0.37–3.68) 0.80 0.99 (0.31–3.17) 0.98
 Anxiety
  No 191 322,595 5.9 246 191,432 12.9 2.17 (1.79–2.62) < 0.001 1.82 (1.48–2.24) < 0.001
  Yes 15 10,526 14.3 195 123,196 15.8 1.11 (0.66–1.88) 0.69 1.04 (0.61–1.77) 0.88

IR Incidence rate per 10,000 person-year

aModel mutually adjusted for sex, age (categorical), diabetes, dyslipidemia, hypertension, depression, anxiety, and ischemic heart disease